
India's Union Budget has exempted customs duty on medicines for certain rare diseases, aiming to reduce treatment costs. Despite this, patients like 17-year-old Nayan with Hunter's Syndrome and 19-year-old Revathi with Gaucher disease face high expenses due to imported, limited-supply drugs. The National Policy for Rare Diseases offers one-time funding up to Rs 50 lakh, but many patients exhaust this support, leaving families to cover ongoing costly treatments. Access and affordability remain significant challenges.
Select a news story to see related coverage from other media outlets.